We observed no difference in the absolute frequency of tumor-infiltrating CD8+ T cells nor an impact on tumor burden (SI Appendix, Fig. S2 C and D), suggesting that TIINDR does not affect accumulation or drive adverse effector function of CD8+ T cells in the tumor. The gene discussed is CD8A; the disease is neoplasm.